ArticleDrug design, development and therapy2020

Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles.

Yun Bian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.